
Eli Diamond
Associate Attending Physician · New York Presbyterian Hospital
Credentials: · · ·
History
- 2007–2010
2003–2007
Research
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
New England Journal of Medicine · 2015 · 1,432 citations
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
Review · Blood · 2016 · 1,128 citations
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial
Archives of General Psychiatry · 1999 · 570 citations

40 papers

33 papers
- JF
20 papers · 2 as a resident
- DH
19 papers
- MR
18 papers

16 papers

16 papers
- RR
15 papers · 2 as a fellow
Grants
- 2021–2028
Molecular Pathogenesis and Therapy of Systemic Histiocytic Neoplasms
National Cancer Institute · R37
Contact PI · $3.3M · Sloan-Kettering Inst Can Research
- 2024
National Center for Advancing Translational Sciences · R13
PI · $30K · St. Jude Children's Research Hospital
- 2016–2017
Fourth International Medical Symposium on Erdheim-Chester Disease
National Center for Advancing Translational Sciences · R13
Contact PI · $10K · Sloan-Kettering Inst Can Research
Clinical trials
- 2024–2027
Ulixertinib in People With Histiocytic Neoplasms
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
- 2019–2027
Principal investigator · Recruiting
Memorial Sloan Kettering Cancer Center
- 2017–2026
Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses
Principal investigator · Recruiting
Memorial Sloan Kettering Cancer Center
- 2017–2027
A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center

